Two StockWatchIndex Biotech IPO Picks Up 75%
Adding Value to the QuickPicks Portfolio  
Los Angeles, July 12, 2017 - StockWatchIndex (SWI) announces today that the two IPO picks it published in late June have all performed well, being up 75% as a group; the entire SWI QuickPicks Portfolio is up 43%. The picks add considerable value to the portfolio and speak loudly for the quality of our research in the BioTech sector.

Aileron Therapeutics closed at $13.68 up from an initial price of $10.75
Dova Therapeutics closed at $26.81 up from an initial price of $12.03

We will continue to  follow our picks closely and will consider adding them to our SWI Portfolio during the next few weeks. Having IPO stocks continue to perform well after an initial IPO bump and subsequent drop, which is typical for most IPOs, is encouraging.

We have dropped Pfenex, Inc (PFNX) from the QuickPicks Portfolio and will replace it with a new stock out of the pool of stocks that are currently being researched by us.
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at to download the reports,
or visit for up to date news on the covered companies.
Please feel free to
re-distribute the reports to your friends and colleagues.
Rainer Poertner - Chief Analyst
S tockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided.  SWI has not been compensated for this report, but may hold or plan to acquire positions of every stock in this report for its portfolio a nd reserves the right to buy or sell positions at its sole  discretion. The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.